Department of Pediatric Nephrology, Dr. Sami Ulus Maternity and Child Health and Diseases Training and Research Hospital, Ankara, Turkey.
Faculty of Engineering, Çanakkale Onsekiz Mart University, Çanakkale, Turkey.
Pediatr Nephrol. 2023 Sep;38(9):3027-3033. doi: 10.1007/s00467-023-05935-9. Epub 2023 Mar 16.
Acute post-streptococcal glomerulonephritis (APSGN) is an immune-mediated inflammatory respsonse in the kidneys caused by nephritogenic strains of group A β-hemolytic streptococcus (GAS). The present study aimed to present a large patient cohort of APSGN patients to determine the factors that can be used for predicting the prognosis and progression to rapidly progressive glomerulonephritis (RPGN).
The study included 153 children with APSGN that were seen between January 2010 and January 2022. Inclusion criteria were age 1-18 years and follow-up of ≥ 1 years. Patients with a diagnosis that could not be clearly proven clinically or via biopsy and with prior clinical or histological evidence of underlying kidney disease or chronic kidney disease (CKD) were excluded from the study.
Mean age was 7.36 ± 2.92 years, and 30.7% of the group was female. Among the 153 patients, 19 (12.4%) progressed to RPGN. The complement factor 3 and albumin levels were significantly low in the patients who had RPGN (P = 0.019). Inflammatory parameters, such as C-reactive protein (CRP), platelet-to-lymphocyte ratio, CRP/albumin ratio, and the erythrocyte sedimentation rate level at presentation were significantly higher in the patients with RPGN (P < 0.05). Additionally, there was a significant correlation between nephrotic range proteinuria and the course of RPGN (P = 0.024).
We suggest the possibility that RPGN can be predicted in APSGN with clinical and laboratory findings. A higher resolution version of the Graphical abstract is available as Supplementary information.
急性链球菌后肾小球肾炎(APSGN)是由 A 群β溶血性链球菌(GAS)的肾炎菌株引起的肾脏免疫介导的炎症反应。本研究旨在介绍一组大型 APSGN 患者,以确定可用于预测预后和进展为快速进行性肾小球肾炎(RPGN)的因素。
本研究纳入了 2010 年 1 月至 2022 年 1 月期间就诊的 153 例 APSGN 患儿。纳入标准为年龄 1-18 岁,随访时间≥1 年。排除临床或活检无法明确诊断且有潜在肾脏疾病或慢性肾脏病(CKD)临床或组织学证据的患者。
平均年龄为 7.36±2.92 岁,30.7%的患者为女性。在 153 例患者中,19 例(12.4%)进展为 RPGN。发生 RPGN 的患者补体因子 3 和白蛋白水平明显较低(P=0.019)。在发生 RPGN 的患者中,炎症参数,如 C 反应蛋白(CRP)、血小板与淋巴细胞比值、CRP/白蛋白比值和红细胞沉降率水平显著升高(P<0.05)。此外,肾病范围蛋白尿与 RPGN 病程之间存在显著相关性(P=0.024)。
我们提出了在 APSGN 中通过临床和实验室发现预测 RPGN 的可能性。一个更高分辨率的图表摘要版本可作为补充信息获得。